Ritholtz Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.06M | Sell |
5,084
-44
| -0.9% | -$17.8K | 0.05% | 288 |
|
|
2025
Q1 | $2.55M | Buy |
5,128
+702
| +16% | +$349K | 0.08% | 192 |
|
|
2024
Q4 | $2.3M | Sell |
4,426
-346
| -7% | -$180K | 0.07% | 199 |
|
|
2024
Q3 | $2.95M | Buy |
4,772
+341
| +8% | +$211K | 0.09% | 157 |
|
|
2024
Q2 | $2.45M | Buy |
4,431
+158
| +4% | +$87.4K | 0.08% | 163 |
|
|
2024
Q1 | $2.48M | Buy |
4,273
+365
| +9% | +$212K | 0.09% | 157 |
|
|
2023
Q4 | $2.07M | Buy |
3,908
+254
| +7% | +$135K | 0.08% | 163 |
|
|
2023
Q3 | $1.85M | Buy |
3,654
+1,041
| +40% | +$527K | 0.08% | 154 |
|
|
2023
Q2 | $1.36M | Sell |
2,613
-927
| -26% | -$484K | 0.06% | 205 |
|
|
2023
Q1 | $2.04M | Buy |
3,540
+476
| +16% | +$274K | 0.1% | 126 |
|
|
2022
Q4 | $1.69M | Sell |
3,064
-1,080
| -26% | -$595K | 0.09% | 152 |
|
|
2022
Q3 | $2.1M | Buy |
4,144
+1,344
| +48% | +$682K | 0.11% | 129 |
|
|
2022
Q2 | $1.52M | Buy |
2,800
+423
| +18% | +$230K | 0.1% | 131 |
|
|
2022
Q1 | $1.4M | Sell |
2,377
-1,269
| -35% | -$750K | 0.09% | 130 |
|
|
2021
Q4 | $2.43M | Buy |
3,646
+108
| +3% | +$72.1K | 0.15% | 66 |
|
|
2021
Q3 | $2.02M | Buy |
3,538
+334
| +10% | +$191K | 0.14% | 72 |
|
|
2021
Q2 | $1.62M | Sell |
3,204
-467
| -13% | -$236K | 0.12% | 83 |
|
|
2021
Q1 | $1.68M | Buy |
3,671
+2,355
| +179% | +$1.07M | 0.14% | 73 |
|
|
2020
Q4 | $613K | Buy |
1,316
+124
| +10% | +$57.8K | 0.06% | 133 |
|
|
2020
Q3 | $526K | Buy |
1,192
+340
| +40% | +$150K | 0.06% | 126 |
|
|
2020
Q2 | $309K | Buy |
852
+75
| +10% | +$27.2K | 0.04% | 172 |
|
|
2020
Q1 | $220K | Sell |
777
-29
| -4% | -$8.21K | 0.04% | 138 |
|
|
2019
Q4 | $262K | Buy |
+806
| New | +$262K | 0.04% | 120 |
|